Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research.

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS.

J Prev Alzheimers Dis. 2019;6(1):2-15. doi: 10.14283/jpad.2018.43.

PMID:
30569080
2.

Sex and gender in Alzheimer's disease - Does it matter?

Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS.

Alzheimers Dement. 2018 Sep;14(9):1101-1103. doi: 10.1016/j.jalz.2018.08.003. No abstract available.

PMID:
30196887
3.

Reduce the burden of dementia now.

Hayden KM, Inouye SK, Cunningham C, Jones RN, Avidan MS, Davis D, Kuchel GA, Tang Y, Khachaturian AS.

Alzheimers Dement. 2018 Jul;14(7):845-847. doi: 10.1016/j.jalz.2018.06.3039. Epub 2018 Jun 28. No abstract available.

PMID:
29959910
4.

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, Khachaturian ZS.

Brain. 2018 Jul 1;141(7):1917-1933. doi: 10.1093/brain/awy132.

PMID:
29850777
5.

New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.

Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS.

Alzheimers Dement. 2018 Jun;14(6):703-706. doi: 10.1016/j.jalz.2018.05.002. Epub 2018 May 26. No abstract available.

PMID:
29842864
6.

Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.

Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gustafson DR, Kukull WA, Mohs R, Khachaturian ZS.

Alzheimers Dement. 2018 Apr;14(4):532-534. doi: 10.1016/j.jalz.2018.03.003. No abstract available.

PMID:
29653605
7.

Letter.

Khachaturian AS.

Alzheimers Dement (Amst). 2017 Nov 21;9:84-87. doi: 10.1016/j.dadm.2017.11.004. eCollection 2017. No abstract available.

8.

WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS; Cholinergic System Working Group.

Alzheimers Dement. 2017 Oct 10. pii: S1552-5260(17)33719-6. doi: 10.1016/j.jalz.2017.08.016. [Epub ahead of print]

PMID:
29028480
9.

Zeroing out preventable disability: Daring to dream the impossible dream for dementia care: Recommendations for a national plan to advance dementia care and maximize functioning.

Khachaturian AS, Hoffman DP, Frank L, Petersen R, Carson BR, Khachaturian ZS.

Alzheimers Dement. 2017 Oct;13(10):1077-1080. doi: 10.1016/j.jalz.2017.09.003. Epub 2017 Sep 19. No abstract available.

PMID:
28935202
10.

Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.

Knopman D, Alford E, Tate K, Long M, Khachaturian AS.

Alzheimers Dement. 2017 Aug;13(8):940-946. doi: 10.1016/j.jalz.2017.06.001. Epub 2017 Jul 11.

PMID:
28709585
11.

Special topic section on health economics and public policy of Alzheimer's disease.

Jönsson L, Lin PJ, Khachaturian AS.

Alzheimers Dement. 2017 Mar;13(3):201-204. doi: 10.1016/j.jalz.2017.02.004. Epub 2017 Feb 21. No abstract available.

PMID:
28232007
12.

Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?

Khachaturian ZS, Mesulam MM, Mohs RC, Khachaturian AS.

Alzheimers Dement. 2016 Mar;12(3):213-5. doi: 10.1016/j.jalz.2016.02.003. No abstract available.

PMID:
27012483
13.

The Paradox of Research on Dementia-Alzheimer's Disease.

Khachaturian ZS, Khachaturian AS.

J Prev Alzheimers Dis. 2016;3(4):189-191. doi: 10.14283/jpad.2016.117. No abstract available.

PMID:
29199320
14.

The Special Topics Section of Alzheimer's & Dementia.

Khachaturian ZS, Mesulam MM, Khachaturian AS, Mohs RC.

Alzheimers Dement. 2015 Nov;11(11):1261-4. doi: 10.1016/j.jalz.2015.10.002. No abstract available.

PMID:
26589667
15.

Politics of science: Progress toward prevention of the dementia-Alzheimer's syndrome.

Khachaturian ZS, Khachaturian AS.

Mol Aspects Med. 2015 Jun-Oct;43-44:3-15. doi: 10.1016/j.mam.2015.06.001. Epub 2015 Jun 5. Review.

PMID:
26054567
16.

Editorial.

Khachaturian AS.

Alzheimers Dement. 2014 Nov;10(6):590-1. doi: 10.1016/j.jalz.2014.10.010. Epub 2014 Nov 15. No abstract available.

PMID:
25458307
17.

Why a woodpecker?

Khachaturian AS.

Alzheimers Dement. 2014 Nov;10(6):587-9. doi: 10.1016/j.jalz.2014.10.001. Epub 2014 Nov 15. No abstract available.

PMID:
25458306
18.

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.

Alzheimer's Association National Plan Milestone Workgroup, Fargo KN, Aisen P, Albert M, Au R, Corrada MM, DeKosky S, Drachman D, Fillit H, Gitlin L, Haas M, Herrup K, Kawas C, Khachaturian AS, Khachaturian ZS, Klunk W, Knopman D, Kukull WA, Lamb B, Logsdon RG, Maruff P, Mesulam M, Mobley W, Mohs R, Morgan D, Nixon RA, Paul S, Petersen R, Plassman B, Potter W, Reiman E, Reisberg B, Sano M, Schindler R, Schneider LS, Snyder PJ, Sperling RA, Yaffe K, Bain LJ, Thies WH, Carrillo MC.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S430-52. doi: 10.1016/j.jalz.2014.08.103.

19.

Military risk factors for Alzheimer's dementia and neurodegenerative disease.

Khachaturian AS, Khachaturian ZS.

Alzheimers Dement. 2014 Jun;10(3 Suppl):S90-1. doi: 10.1016/j.jalz.2014.05.1085. No abstract available.

20.

Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.

Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M.

J Intern Med. 2014 Mar;275(3):304-16. doi: 10.1111/joim.12167.

21.

Advances in the prevention of Alzheimer's disease and dementia.

Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M.

J Intern Med. 2014 Mar;275(3):229-50. doi: 10.1111/joim.12178.

22.

Top 20 articles cited from Alzheimer's & Dementia since 2008.

Khachaturian AS.

Alzheimers Dement. 2013 Nov;9(6):619-21. doi: 10.1016/j.jalz.2013.10.001. No abstract available.

PMID:
24199851
23.

Big data, aging, and dementia: pathways for international harmonization on data sharing.

Khachaturian AS, Meranus DH, Kukull WA, Khachaturian ZS.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S61-2. doi: 10.1016/j.jalz.2013.09.001. No abstract available.

24.

Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease.

Carrillo MC, Brashear HR, Logovinsky V, Ryan JM, Feldman HH, Siemers ER, Abushakra S, Hartley DM, Petersen RC, Khachaturian AS, Sperling RA.

Alzheimers Dement. 2013 Mar;9(2):123-131.e1. doi: 10.1016/j.jalz.2012.12.004. Epub 2013 Feb 12. Review.

PMID:
23411394
25.

Vascular diseases: one pathway toward new conceptual models of dementia.

Mielke MM, Montine T, Khachaturian AS.

Alzheimers Dement. 2012 Oct;8(5 Suppl):S69-70. doi: 10.1016/j.jalz.2012.09.001. No abstract available.

PMID:
23021623
26.

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.

Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, Feinberg LF, Frisoni G, Green C, Guimaraes RM, Gwyther LP, Hefti FF, Hutton M, Kawas C, Kent DM, Kuller L, Langa KM, Mahley RW, Maslow K, Masters CL, Meier DE, Neumann PJ, Paul SM, Petersen RC, Sager MA, Sano M, Schenk D, Soares H, Sperling RA, Stahl SM, van Deerlin V, Stern Y, Weir D, Wolk DA, Trojanowski JQ.

Alzheimers Dement. 2012 Sep;8(5):445-52. doi: 10.1016/j.jalz.2012.08.001.

27.

NAPA 2.0: the next giant leap.

Khachaturian AS, Paul SM, Khachaturian ZS.

Alzheimers Dement. 2012 Sep;8(5):379-80. doi: 10.1016/j.jalz.2012.08.002. No abstract available.

PMID:
22959697
28.

Biomarker development: a population-level perspective.

Khachaturian AS, Mielke MM, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):247-9. doi: 10.1016/j.jalz.2012.06.002. No abstract available.

PMID:
22748935
29.

The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.

Yaffe K, Tocco M, Petersen RC, Sigler C, Burns LC, Cornelius C, Khachaturian AS, Irizarry MC, Carrillo MC.

Alzheimers Dement. 2012 May;8(3):237-42. doi: 10.1016/j.jalz.2011.12.005.

PMID:
22546356
30.

The draft "National Plan" to address Alzheimer's disease - National Alzheimer's Project Act (NAPA).

Khachaturian ZS, Khachaturian AS, Thies W.

Alzheimers Dement. 2012 May;8(3):234-6. doi: 10.1016/j.jalz.2012.04.004.

PMID:
22546355
31.

Countrywide strategic plans on Alzheimer's disease: developing the framework for the international battle against Alzheimer's disease.

Rosow K, Holzapfel A, Karlawish JH, Baumgart M, Bain LJ, Khachaturian AS.

Alzheimers Dement. 2011 Nov;7(6):615-21. doi: 10.1016/j.jalz.2011.09.226. Review.

PMID:
22055978
32.

Neuropsychiatric symptoms in Alzheimer's disease.

Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS.

Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410.

33.

Assessment of cognition in mild cognitive impairment: a comparative study.

Snyder PJ, Jackson CE, Petersen RC, Khachaturian AS, Kaye J, Albert MS, Weintraub S.

Alzheimers Dement. 2011 May;7(3):338-55. doi: 10.1016/j.jalz.2011.03.009. Review.

34.

Global issues in drug development for Alzheimer's disease.

Doody RS, Cole PE, Miller DS, Siemers E, Black R, Feldman H, Schindler R, Graham S, Heath T, Khachaturian AS, Evans R, Carrillo MC.

Alzheimers Dement. 2011 Mar;7(2):197-207. doi: 10.1016/j.jalz.2011.01.001.

PMID:
21414556
35.

Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.

Khachaturian ZS, Petersen RC, Snyder PJ, Khachaturian AS, Aisen P, de Leon M, Greenberg BD, Kukull W, Maruff P, Sperling RA, Stern Y, Touchon J, Vellas B, Andrieu S, Weiner MW, Carrillo MC, Bain LJ.

Alzheimers Dement. 2011 Mar;7(2):127-32. doi: 10.1016/j.jalz.2011.02.005.

PMID:
21414553
36.

Revision of the criteria for Alzheimer’s disease: A symposium.

DeKosky ST, Carrillo MC, Phelps C, Knopman D, Petersen RC, Frank R, Schenk D, Masterman D, Siemers ER, Cedarbaum JM, Gold M, Miller DS, Morimoto BH, Khachaturian AS, Mohs RC.

Alzheimers Dement. 2011 Jan;7(1):e1-12.

PMID:
21322828
37.

A tribute to the Extramural Epidemiology Program, National Institute on Aging.

Khachaturian AS.

Alzheimers Dement. 2011 Jan;7(1):1-2. doi: 10.1016/j.jalz.2010.12.001. No abstract available.

PMID:
21255738
38.

Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database project.

Khachaturian AS, Chapman J, Farrer L, Friedland RP, Ebstein R, Grossman I, Hendler T, Hermann B, Inzelberg R, Johnson S, Khachaturian ZS, Lichter-Shapira I, Makeeva O, Mayrl R, Mizrahi E, Roses AD, Sager M, Fraifeld S.

Alzheimers Dement. 2010 Nov;6(6):475-81. doi: 10.1016/j.jalz.2010.10.001.

PMID:
21044777
39.

Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Creating a national database for successful aging.

Khachaturian AS, Sabbagh M.

Alzheimers Dement. 2010 Mar;6(2):132-4. doi: 10.1016/j.jalz.2010.01.012. No abstract available.

PMID:
20298973
40.

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

Khachaturian ZS, Barnes D, Einstein R, Johnson S, Lee V, Roses A, Sager MA, Shankle WR, Snyder PJ, Petersen RC, Schellenberg G, Trojanowski J, Aisen P, Albert MS, Breitner JC, Buckholtz N, Carrillo M, Ferris S, Greenberg BD, Grundman M, Khachaturian AS, Kuller LH, Lopez OL, Maruff P, Mohs RC, Morrison-Bogorad M, Phelps C, Reiman E, Sabbagh M, Sano M, Schneider LS, Siemers E, Tariot P, Touchon J, Vellas B, Bain LJ.

Alzheimers Dement. 2010 Mar;6(2):89-97. doi: 10.1016/j.jalz.2010.01.008.

41.

Creating a transatlantic research enterprise for preventing Alzheimer's disease.

Khachaturian ZS, Camí J, Andrieu S, Avila J, Boada Rovira M, Breteler M, Froelich L, Gauthier S, Gómez-Isla T, Khachaturian AS, Kuller LH, Larson EB, Lopez OL, Martinez-Lage JM, Petersen RC, Schellenberg GD, Sunyer J, Vellas B, Bain LJ.

Alzheimers Dement. 2009 Jul;5(4):361-6. doi: 10.1016/j.jalz.2009.05.158.

42.

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom JP, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ.

Alzheimers Dement. 2009 Mar;5(2):85-92. doi: 10.1016/j.jalz.2009.01.021.

43.

Prevent Alzheimer's disease by 2020: a national strategic goal.

Khachaturian ZS, Khachaturian AS.

Alzheimers Dement. 2009 Mar;5(2):81-4. doi: 10.1016/j.jalz.2009.01.022. No abstract available.

PMID:
19328433
44.

Diagnosis and assessment of Alzheimer's disease in diverse populations.

Dilworth-Anderson P, Hendrie HC, Manly JJ, Khachaturian AS, Fazio S; Social, Behavioral and Diversity Research Workgroup of the Alzheimer;s Association.

Alzheimers Dement. 2008 Jul;4(4):305-9. doi: 10.1016/j.jalz.2008.03.001. Epub 2008 Apr 21. No abstract available.

PMID:
18631983
45.

Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study.

Fotuhi M, Zandi PP, Hayden KM, Khachaturian AS, Szekely CA, Wengreen H, Munger RG, Norton MC, Tschanz JT, Lyketsos CG, Breitner JC, Welsh-Bohmer K.

Alzheimers Dement. 2008 May;4(3):223-7. doi: 10.1016/j.jalz.2008.01.004. Epub 2008 Apr 21.

46.

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.

Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ.

Alzheimers Dement. 2008 May;4(3):156-63. doi: 10.1016/j.jalz.2008.03.005. No abstract available.

47.

New thinking about thinking.

Khachaturian AS.

Alzheimers Dement. 2008 May;4(3):155. doi: 10.1016/j.jalz.2008.04.002. No abstract available.

PMID:
18631959
48.

Does NSAID use modify cognitive trajectories in the elderly? The Cache County study.

Hayden KM, Zandi PP, Khachaturian AS, Szekely CA, Fotuhi M, Norton MC, Tschanz JT, Pieper CF, Corcoran C, Lyketsos CG, Breitner JC, Welsh-Bohmer KA; Cache County Investigators.

Neurology. 2007 Jul 17;69(3):275-82.

PMID:
17636065
49.

The Nevada Vital Aging Initiative: a private-public partnership to study early predictors of dementia.

Thal L, Kuller L, Bowman K, Breitner J, Evans D, Farrer L, Frank R, Khachaturian AS, Khachaturian ZS, Kukull W, Nieto J, Petersen R, Sager M, Scherr P, Bain LJ.

Alzheimers Dement. 2007 Jan;3(1):62-7. doi: 10.1016/j.jalz.2006.11.002. No abstract available.

PMID:
19595919
50.

Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study.

Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA; Cache County Investigators.

Alzheimer Dis Assoc Disord. 2006 Apr-Jun;20(2):93-100.

PMID:
16772744

Supplemental Content

Loading ...
Support Center